FRI-473-Safety and effectiveness of regorafenib in recurrent HCC after liver transplantation and progression on sorafenib: A real-life multicentre study

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • ISSN:
      0168-8278
    • Accession Number:
      10.1016/S0618-8278(19)31209-5
    • Accession Number:
      S0618827819312095
    • Copyright:
      Copyright © 2019 European Association for the Study of the Liver on behalf of European Association for the Study of the Liver All rights reserved.
  • Citations
    • ABNT:
      LAVARONE, M. et al. FRI-473-Safety and effectiveness of regorafenib in recurrent HCC after liver transplantation and progression on sorafenib: A real-life multicentre study. Journal of Hepatology, [s. l.], v. 70, n. 1, p. e606–e607, 2019. DOI 10.1016/S0618-8278(19)31209-5. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edselp&AN=S0618827819312095. Acesso em: 1 dez. 2020.
    • AMA:
      Lavarone M, Invernizzi F, Czauderna C, et al. FRI-473-Safety and effectiveness of regorafenib in recurrent HCC after liver transplantation and progression on sorafenib: A real-life multicentre study. Journal of Hepatology. 2019;70(1):e606-e607. doi:10.1016/S0618-8278(19)31209-5
    • APA:
      Lavarone, M., Invernizzi, F., Czauderna, C., Zamparelli, M. S., Bhoori, S., Amaddeo, G., Manini, M. A., Fraile, M., Anders, M. M., Pinter, M., Rodriguez, M. J. B., Romero, M., Alejandro, A. S. G., Pinero, F., Villadsen, G. E., Weinmann, A., Crespo, G., Mazzaferro, V., Regnault, H., … Reig, M. (2019). FRI-473-Safety and effectiveness of regorafenib in recurrent HCC after liver transplantation and progression on sorafenib: A real-life multicentre study. Journal of Hepatology, 70(1), e606–e607. https://doi.org/10.1016/S0618-8278(19)31209-5
    • Chicago/Turabian: Author-Date:
      Lavarone, Massimo, Federica Invernizzi, Carolin Czauderna, Marco Sanduzzi Zamparelli, Sherrie Bhoori, Giuliana Amaddeo, Matteo Angelo Manini, et al. 2019. “FRI-473-Safety and Effectiveness of Regorafenib in Recurrent HCC after Liver Transplantation and Progression on Sorafenib: A Real-Life Multicentre Study.” Journal of Hepatology 70 (1): e606–7. doi:10.1016/S0618-8278(19)31209-5.
    • Harvard:
      Lavarone, M. et al. (2019) ‘FRI-473-Safety and effectiveness of regorafenib in recurrent HCC after liver transplantation and progression on sorafenib: A real-life multicentre study’, Journal of Hepatology, 70(1), pp. e606–e607. doi: 10.1016/S0618-8278(19)31209-5.
    • Harvard: Australian:
      Lavarone, M, Invernizzi, F, Czauderna, C, Zamparelli, MS, Bhoori, S, Amaddeo, G, Manini, MA, Fraile, M, Anders, MM, Pinter, M, Rodriguez, MJB, Romero, M, Alejandro, ASG, Pinero, F, Villadsen, GE, Weinmann, A, Crespo, G, Mazzaferro, V, Regnault, H, Giorgio, MD, Dieguez, MLG, Donato, MF, Varela, M, Marcus, W, Bruix, J, Lampertico, P & Reig, M 2019, ‘FRI-473-Safety and effectiveness of regorafenib in recurrent HCC after liver transplantation and progression on sorafenib: A real-life multicentre study’, Journal of Hepatology, vol. 70, no. 1, pp. e606–e607, viewed 1 December 2020, .
    • MLA:
      Lavarone, Massimo, et al. “FRI-473-Safety and Effectiveness of Regorafenib in Recurrent HCC after Liver Transplantation and Progression on Sorafenib: A Real-Life Multicentre Study.” Journal of Hepatology, vol. 70, no. 1, Apr. 2019, pp. e606–e607. EBSCOhost, doi:10.1016/S0618-8278(19)31209-5.
    • Chicago/Turabian: Humanities:
      Lavarone, Massimo, Federica Invernizzi, Carolin Czauderna, Marco Sanduzzi Zamparelli, Sherrie Bhoori, Giuliana Amaddeo, Matteo Angelo Manini, et al. “FRI-473-Safety and Effectiveness of Regorafenib in Recurrent HCC after Liver Transplantation and Progression on Sorafenib: A Real-Life Multicentre Study.” Journal of Hepatology 70, no. 1 (April 1, 2019): e606–7. doi:10.1016/S0618-8278(19)31209-5.
    • Vancouver/ICMJE:
      Lavarone M, Invernizzi F, Czauderna C, Zamparelli MS, Bhoori S, Amaddeo G, et al. FRI-473-Safety and effectiveness of regorafenib in recurrent HCC after liver transplantation and progression on sorafenib: A real-life multicentre study. Journal of Hepatology [Internet]. 2019 Apr 1 [cited 2020 Dec 1];70(1):e606–7. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edselp&AN=S0618827819312095